81岁美国国家过敏症和传染病研究所所长福奇新冠病毒检测结果呈阳性,症状轻微

2022-06-17 网络 网络

当地时间2022年6月15日,据美国国家过敏症和传染病研究所发布消息,该研究所所长福奇(Anthony S. Fauci)博士新冠病毒检测结果呈阳性,症状轻微。图为当地时间2022年5月17日,美国华

当地时间2022年6月15日,据美国国家过敏症和传染病研究所发布消息,该研究所所长福奇(Anthony S. Fauci)博士新冠病毒检测结果呈阳性,症状轻微。福奇现年81岁,1984年起出任美国国家过敏症和传染病研究所所长。

图片

图为当地时间2022年5月17日,美国华盛顿特区,美国国家过敏症和传染病研究所所长福奇出席参议院劳工、卫生与公众服务、教育及相关机构拨款小组委员会听证会。

美国国家卫生研究院15日发表声明说,美国国家过敏症和传染病研究所所长安东尼·福奇新冠病毒检测结果呈阳性,目前症状轻微,将居家办公。

声明说,福奇接受新冠病毒快速抗原检测结果呈阳性。他此前已完成新冠疫苗全程接种并打过两次加强针。他最近没有与总统约瑟夫·拜登或其他政府高级官员密切接触过。

福奇将居家隔离、办公,“将遵守(美国)疾病控制和预防中心防疫指南,听取他的医生的医学建议,待检测结果呈阴性后再返回国家卫生研究院工作”。

国家过敏症和传染病研究所为国家卫生研究院下辖27个研究机构之一。所长福奇是拜登总统首席医疗顾问。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1801085, encodeId=db1c1801085e8, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Tue Dec 20 15:50:26 CST 2022, time=2022-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935225, encodeId=4a341935225d3, content=<a href='/topic/show?id=642358069a3' target=_blank style='color:#2F92EE;'>#新冠病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58069, encryptionId=642358069a3, topicName=新冠病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Wed Jul 20 21:50:26 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083719, encodeId=52d12083e1963, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue Apr 11 00:50:26 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491115, encodeId=ecc314911157a, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6758872583, createdName=luoxiaog, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516463, encodeId=781715164639b, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1801085, encodeId=db1c1801085e8, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Tue Dec 20 15:50:26 CST 2022, time=2022-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935225, encodeId=4a341935225d3, content=<a href='/topic/show?id=642358069a3' target=_blank style='color:#2F92EE;'>#新冠病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58069, encryptionId=642358069a3, topicName=新冠病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Wed Jul 20 21:50:26 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083719, encodeId=52d12083e1963, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue Apr 11 00:50:26 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491115, encodeId=ecc314911157a, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6758872583, createdName=luoxiaog, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516463, encodeId=781715164639b, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1801085, encodeId=db1c1801085e8, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Tue Dec 20 15:50:26 CST 2022, time=2022-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935225, encodeId=4a341935225d3, content=<a href='/topic/show?id=642358069a3' target=_blank style='color:#2F92EE;'>#新冠病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58069, encryptionId=642358069a3, topicName=新冠病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Wed Jul 20 21:50:26 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083719, encodeId=52d12083e1963, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue Apr 11 00:50:26 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491115, encodeId=ecc314911157a, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6758872583, createdName=luoxiaog, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516463, encodeId=781715164639b, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1801085, encodeId=db1c1801085e8, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Tue Dec 20 15:50:26 CST 2022, time=2022-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935225, encodeId=4a341935225d3, content=<a href='/topic/show?id=642358069a3' target=_blank style='color:#2F92EE;'>#新冠病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58069, encryptionId=642358069a3, topicName=新冠病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Wed Jul 20 21:50:26 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083719, encodeId=52d12083e1963, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue Apr 11 00:50:26 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491115, encodeId=ecc314911157a, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6758872583, createdName=luoxiaog, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516463, encodeId=781715164639b, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1801085, encodeId=db1c1801085e8, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Tue Dec 20 15:50:26 CST 2022, time=2022-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935225, encodeId=4a341935225d3, content=<a href='/topic/show?id=642358069a3' target=_blank style='color:#2F92EE;'>#新冠病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58069, encryptionId=642358069a3, topicName=新冠病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Wed Jul 20 21:50:26 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083719, encodeId=52d12083e1963, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Tue Apr 11 00:50:26 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491115, encodeId=ecc314911157a, content=<a href='/topic/show?id=db91e095978' target=_blank style='color:#2F92EE;'>#病毒检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70959, encryptionId=db91e095978, topicName=病毒检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6758872583, createdName=luoxiaog, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516463, encodeId=781715164639b, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sat Jun 18 16:50:26 CST 2022, time=2022-06-18, status=1, ipAttribution=)]

相关资讯

新冠疫苗研发速度如此之快,为什么HIV疫苗就这么难?

HIV病毒新突变的速度远远大于新冠病毒。

国家卫健委:昨日全国新冠病毒感染疫情最新情况,本土新增54+65例,其中北京25+38例(2022.6.15)

6月14日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例77例。其中境外输入病例23例(上海5例,福建5例,广东5例,浙江2例,四川2例,天津1例,江苏1例,湖南

美国卫生部长30天内两次感染新冠!有美国人曾重复五次感染

当地时间6月13日,美国卫生部发表声明称,美国卫生部长哈维尔·贝塞拉在当天的新冠病毒检测中呈阳性。这是贝塞拉在30天内第二次感染新冠。

Nature:流感疫苗能降低新冠重症90%,有奇效!这,啥意思?

《自然》近日发表文章称,一项对卡塔尔3万多名卫生保健工作者的研究发现,流感疫苗可能可以预防新冠病毒,尤其是在新冠重症防护方面效果显著。不过,目前尚不清楚这其中的原因,也不确定流感疫苗对新冠病毒的防护效

香港真实世界研究结果显示Paxlovid治疗新冠病毒感染优于Molnupiravir

这项回顾性研究分析了2022年2.26-4.26香港Omicron BA.2疫情期间使用Paxlovid和Molnupiravir两款口服药治疗